{"symbol": "AGIO", "companyName": "Agios Pharmaceuticals Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.agios.com", "description": "Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.", "CEO": "David P. Schenkein", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}